The origin and evolution of mutations in acute myeloid leukemia

Welch, John S., Ley, Timothy J., Link, Daniel C., Miller, Christopher A., Larson, David E., Koboldt, Daniel C., Wartman, Lukas D., Lamprecht, Tamara L. +46 more·2012·Cell

Cited by (1,001)

Items 601–700 of 1,001

  1. Comparison of clonal architecture between primary and immunodeficient mouse-engrafted acute myeloid leukemia cells
    Naomi Kawashima, Yuichi Ishikawa, Jeong Hui Kim, Yoko Ushijima, Akimi Akashi, Yohei Yamaguchi, Hikaru Hattori, Marie Nakashima, Seara Ikeno, Rika Kihara et al. · 2022 · Nature Communications
  2. Human circulating small non-coding RNA signature as a non-invasive biomarker in clinical diagnosis of acute myeloid leukaemia
    Xia Lin, Huanping Guo, Xiao Wu, Yinying Xu, Pan Zhao, Bingbing Yan, Yunjing Zeng, Yundi He, Dan Chen, Robert Peter Gale et al. · 2023 · Theranostics
  3. NrasG12D oncoprotein inhibits apoptosis of preleukemic cells expressing Cbfβ-SMMHC via activation of MEK/ERK axis
    Liting Xue, John Anto Pulikkan, Peter J.M. Valk, Lucio Hernán Castilla · 2014 · Blood
  4. Integrated clinical, whole-genome, and transcriptome analysis of multisampled lethal metastatic prostate cancer
    G. Steven Bova, Heini M. L. Kallio, Matti Annala, Kati K. Kivinummi, Gunilla Högnäs, Sergei Häyrynen, Tommi Rantapero, Virpi Kivinen, William B. Isaacs, Teemu T. Tolonen et al. · 2016 · Molecular Case Studies
  5. The clinical significance of negative flow cytometry immunophenotypic results in a morphologically scored positive bone marrow in patients following treatment for acute myeloid leukemia
    Juan Ouyang, Maitrayee Goswami, Guilin Tang, Jie Peng, Farhad Ravandi, Naval Guastad Daver, Mark J. Routbort, Sergej Naumovich Konoplev, Pei Lin, Leonard Jeffrey Medeiros et al. · 2015 · American Journal of Hematology
  6. Advances in treating acute myeloid leukemia
    Margaret M. Showel, Mark J. Levis · 2014 · F1000Prime Reports
  7. A multigene array for measurable residual disease detection in AML patients undergoing SCT
    Meghali Goswami, Katherine S. McGowan, Kit Yu Lu, Natasha A. Jain, Julián Candia, Nancy F. Hensel, Jinhua Tang, Katherine R. Calvo, Minoo Battiwalla, A. John Barrett et al. · 2015 · Bone Marrow Transplantation
  8. Can we deconstruct cancer, one patient at a time?
    C. Anthony Blau, Effie Liakopoulou · 2012 · Trends in Genetics
  9. Genome stability: What we have learned from cohesinopathies
    Francesco Cucco, Antonio Musio · 2016 · American Journal of Medical Genetics Part C Seminars in Medical Genetics
  10. Emergence of heterogeneity in acute leukemias
    Thomas Stiehl, Christoph Lutz, Anna K. Marciniak-Czochra · 2016 · Biology Direct
  11. Genetic and epigenetic heterogeneity and the impact on cancer relapse
    Ciaran Hassan, Ebrahim Afshinnekoo, Sheng Li, Shixiu Wu, Christopher E. Mason · 2017 · Experimental Hematology
  12. When to obtain genomic data in acute myeloid leukemia (AML) and which mutations matter
    Gregory W. Roloff, Elizabeth A. Griffiths · 2018 · Hematology
  13. Genomic Aging, Clonal Hematopoiesis, and Cardiovascular Disease
    Pradeep Natarajan · 2022 · Arteriosclerosis Thrombosis and Vascular Biology
  14. Synthetic Genetic Targeting of Genome Instability in Cancer
    Babu V. Sajesh, Brent J. Guppy, Kirk James McManus · 2013 · Cancers
  15. Genomic and functional integrity of the hematopoietic system requires tolerance of oxidative DNA lesions
    Ana Martín-Pardillos, Anastasia Tsaalbi‐Shtylik, Si Chen, Seka Lazare, Ronald P. van Os, Albertina Dethmers-Ausema, Nima Borhan Fakouri, Matthias Bosshard, Rossana Aprigliano, Barbara van Loon et al. · 2017 · Blood
  16. Targeting Immunophenotypic Markers on Leukemic Stem Cells: How Lessons from Current Approaches and Advances in the Leukemia Stem Cell (LSC) Model Can Inform Better Strategies for Treating Acute Myeloid Leukemia (AML)
    Kelly Mitchell, Ulrich G. Steidl · 2019 · Cold Spring Harbor Perspectives in Medicine
  17. Does everyone develop covert cancer?
    Melvyn F. Greaves · 2014 · Nature reviews. Cancer
  18. Molecular Minimal Residual Disease Monitoring in Acute Myeloid Leukemia
    Adrian Gabriel Selim, Andrew S. Moore · 2018 · Journal of Molecular Diagnostics
  19. Clonal hematopoiesis and VEXAS syndrome: survival of the fittest clones?
    Yael N. Kusne, Jenna A. Fernandez, Mrinal M. Patnaik · 2021 · Seminars in Hematology
  20. Targeting Chemotherapy to Decondensed H3K27me3-Marked Chromatin of AML Cells Enhances Leukemia Suppression
    Patrizia Porazzi, Svetlana Petruk, Luca Pagliaroli, Marco De Dominici, David Deming, Matthew V. Puccetti, Saul Kushinsky, Gaurav Kumar, Valentina Minieri, Elisa Barbieri et al. · 2021 · Cancer Research
  21. Phenotypically-defined stages of leukemia arrest predict main driver mutations subgroups, and outcome in acute myeloid leukemia
    François Vergez, Laëtitia Largeaud, Sarah Bertoli, Marie-Laure Nicolau-Travers, Jean‐Baptiste Rieu, Inès Vergnolle, Estelle Saland, Audrey Sarry, Suzanne Tavitian, Françoise Huguet et al. · 2022 · Blood Cancer Journal
  22. Mesenchymal stromal cell senescence in haematological malignancies
    Natalya Plakhova, Vasilios Panagopoulos, Kate Vandyke, Andrew C.W. Zannettino, Krzysztof Marek Mrozik · 2023 · Cancer and Metastasis Reviews
  23. Genetically Modified T-Cell-Based Adoptive Immunotherapy in Hematological Malignancies
    Baixin Ye, Creed M. Stary, Gao Qingping, Qiongyu Wang, Zhi Rong Zeng, Zhihong Jian, Lijuan Gu, Xiaoxing Xiong · 2017 · Journal of Immunology Research
  24. Dissecting the Genetic and Non-Genetic Heterogeneity of Acute Myeloid Leukemia Using Next-Generation Sequencing and In Vivo Models
    Rhea H. Desai, Niloofar Zandvakili, Stefan K. Bohlander · 2022 · Cancers
  25. Clinical application of molecular residual disease detection by circulation tumor DNA in solid cancers and a comparison of technologies: review article
    Qiantong Dong, Chenbin Chen, Yuanbo Hu, Weiteng Zhang, Xinxin Yang, Yingxue Qi, Chan Zhu, Xiaodong Chen, Xian Shen, Weiping Ji · 2023 · Cancer Biology & Therapy
  26. STAG2 mutations reshape the cohesin-structured spatial chromatin architecture to drive gene regulation in acute myeloid leukemia
    Alexander H. Fischer, Benjamín Hernández-Rodríguez, Roger Mulet‐Lazaro, Margit Nuetzel, Fabian Hölzl, Stanley van Herk, François G. Kavelaars, Hanna Stanewsky, Ute Ackermann, Amadou H. Niang et al. · 2024 · Cell Reports
  27. Aging, clonal hematopoiesis and preleukemia: not just bad luck?
    Liran I. Shlush, Sasan Zandi, Shalev Itzkovitz, Andre C. Schuh · 2015 · International Journal of Hematology
  28. Cathepsin G is broadly expressed in acute myeloid leukemia and is an effective immunotherapeutic target
    Gheath Alatrash, Haven R. Garber, M. Zhang, Pariya Sukhumalchandra, Yihua Qiu, Haroon Jakher, Alexander A. Perakis, L Becker, Sang‐Bae Yoo, Karen Clise Dwyer et al. · 2016 · Leukemia
  29. Fetal and neonatal hematopoietic progenitors are functionally and transcriptionally resistant to Flt3-ITD mutations
    Shaina N. Porter, Andrew S. Cluster, Wei Yang, Kelsey A Busken, Riddhi M. Patel, Jiyeon Ryoo, Jeffrey A. Magee · 2016 · eLife
  30. Inherited Susceptibility to Hematopoietic Malignancies in the Era of Precision Oncology
    Gregory W. Roloff, Michael William Drazer, Lucy A. Godley · 2021 · JCO Precision Oncology
  31. From the (Epi)Genome to Metabolism and Vice Versa; Examples from Hematologic Malignancy
    Panagiota Karagianni, Stavroula Giannouli, Michael Voulgarelis · 2021 · International Journal of Molecular Sciences
  32. Relapsed acute myeloid leukemia in children and adolescents: current treatment options and future strategies
    Sara Zarnegar‐Lumley, Kenneth J. Caldwell, Jeffrey E. Rubnitz · 2022 · Leukemia
  33. Sequencing of Candidate Chromosome Instability Genes in Endometrial Cancers Reveals Somatic Mutations in ESCO1, CHTF18, and MRE11A
    Jessica C. Price, Lana M. Pollock, Meghan L. Rudd, Sarah K. Fogoros, Hassan Mohamed, Christin L. Hanigan, Matthieu Le Gallo, Suiyuan Zhang, Pedro Cruz, Praveen F. Cherukuri et al. · 2013 · PLoS ONE
  34. Aging: Somatic Mutations, Epigenetic Drift and Gene Dosage Imbalance.
    R. Veitia, D. Govindaraju, S. Bottani, J. Birchler · 2017 · Trends in Cell Biology
  35. Minimal Residual Disease in Acute Myeloid Leukemia: Old and New Concepts
    Mathias Chéa, Lucie Rigolot, Alban Canali, François Vergez · 2024 · International Journal of Molecular Sciences
  36. MRBEE: A bias-corrected multivariable Mendelian randomization method
    Noah J Lorincz‐Comi, Yihe Yang, Gen Li, Xiaofeng Zhu · 2024 · Human Genetics and Genomics Advances
  37. Advancing the Minimal Residual Disease Concept in Acute Myeloid Leukemia
    Peter Hokland, Hans Beier Ommen, Matthew P. Mulè, Christopher Simon Hourigan · 2015 · Seminars in Hematology
  38. Patient‐tailored analysis of minimal residual disease in acute myeloid leukemia using next‐generation sequencing
    Erik Delsing Malmberg, Sara Ståhlman, Anna Rehammar, Tore Samuelsson, Sofie Johansson Alm, Erik Kristiansson, Jonas Abrahamsson, Hege Gravdahl Garelius, Louise Pettersson, Mats Ehinger et al. · 2016 · European Journal Of Haematology
  39. Mutational dynamics of early and late relapsed childhood ALL: rapid clonal expansion and long-term dormancy
    Jean-François Spinella, Chantal Richer, Pauline Cassart, Manon Ouimet, Jasmine Healy, Daniel Sinnett · 2018 · Blood Advances
  40. A decade with whole exome sequencing in haematology
    Marcus Høy Hansen, Torsten Haferlach, Charlotte Guldborg Nyvold · 2019 · British Journal of Haematology
  41. MicroRNA-21/PDCD4 Proapoptotic Signaling From Circulating CD34+ Cells to Vascular Endothelial Cells: A Potential Contributor to Adverse Cardiovascular Outcomes in Patients With Critical Limb Ischemia
    Gaia Spinetti, Elena Sangalli, Elena Tagliabue, Davide Maselli, Ornella Colpani, David Ferland-McCollough, Franco Carnelli, Patrizia Orlando, Agostino Paccagnella, Anna Furlan et al. · 2020 · Diabetes Care
  42. Insights into clonal hematopoiesis and its relation to cancer risk
    Shaneice Renee Mitchell, Jayakrishnan Gopakumar, Siddhartha Jaiswal · 2021 · Current Opinion in Genetics & Development
  43. Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
    Eunbee Park, Megan A. Evans, Heather Doviak, Keita Horitani, Hayato Ogawa, Yoshimitsu Yura, Ying Wang, Soichi Sano, Kenneth Walsh · 2021 · Journal of Visualized Experiments
  44. Mutation Signatures of Pediatric Acute Myeloid Leukemia and Normal Blood Progenitors Associated with Differential Patient Outcomes
    Arianne M. Brandsma, Eline J.M. Bertrums, Markus J. van Roosmalen, Damon A. Hofman, Rurika Oka, Mark Verheul, Freek Manders, Joske Ubels, Mirjam E. Belderbos, Ruben van Boxtel · 2021 · Blood Cancer Discovery
  45. Technical Advances in the Measurement of Residual Disease in Acute Myeloid Leukemia
    Gregory W. Roloff, Catherine Lai, Christopher Simon Hourigan, Laura Williams Dillon · 2017 · Journal of Clinical Medicine
  46. Clonal architecture evolution in Myeloproliferative Neoplasms: from a driver mutation to a complex heterogeneous mutational and phenotypic landscape
    Nabih Maslah, Lina Benajiba, Stéphane Giraudier, Jean‐Jacques Kiladjian, Bruno Cassinat · 2023 · Leukemia
  47. Single-cell proteomics: potential implications for cancer diagnostics
    Sonia Gavasso, Stein‐Erik Gullaksen, Jørn Skavland, Bjørn Tore Gjertsen · 2016 · Expert Review of Molecular Diagnostics
  48. Prognostic significance of recurring chromosomal abnormalities in transplanted patients with acute myeloid leukemia
    Jonathan Canaani, Myriam Labopin, Maija Itälä‐Remes, Didier Blaise, Gèrard Socié, Édouard Forcade, Johan A. Maertens, Depei Wu, Ram K. Malladi, Jan J. Cornelissen et al. · 2019 · Leukemia
  49. The acute myeloid leukemia‐associated Nucleophosmin 1 gene mutations dictate amyloidogenicity of the C‐terminal domain
    Sara La Manna, Pasqualina Liana Scognamiglio, Valentina Roviello, Fabio Borbone, Daniele Florio, Concetta Di Natale, Alessandra Bigi, Cristina Cecchi, Roberta Cascella, Cinzia Giannini et al. · 2019 · FEBS Journal
  50. Towards a Better Understanding of Cohesin Mutations in AML
    Sergi Cuartero, Andrew J. Innes, Matthias Merkenschlager · 2019 · Frontiers in Oncology
  51. Post-transcriptional control of cellular differentiation by the RNA exosome complex
    Isabela Fraga de Andrade, Charu Mehta, Emery H. Bresnick · 2020 · Nucleic Acids Research
  52. Clinical and molecular characterization of myeloid sarcoma without medullary leukemia
    Hussein A. Abbas, Patrick Kevin Reville, Alexis Geppner, Caitlin R. Rausch, Naveen Pemmaraju, Maro N. Ohanian, Koji Sasaki, Gautam M. Borthakur, Naval Guastad Daver, Courtney Denton Dinardo et al. · 2021 · Leukemia & lymphoma/Leukemia and lymphoma
  53. Targeting Measurable Residual Disease (MRD) in Acute Myeloid Leukemia (AML): Moving beyond Prognostication
    Ing Soo Tiong, Sun Loo · 2023 · International Journal of Molecular Sciences
  54. Clonal history of a cord blood donor cell leukemia with prenatal somatic JAK2 V617F mutation
    Pierre Hirsch, Anne‐Claire Mamez, Ramdane Belhocine, Simona Lapusan, Ruoping Tang, Ludovic Suner, D. Bories, Christophe Marzac, Fanny Fava, Ollivier Legrand et al. · 2016 · Leukemia
  55. Mutated clones are the new normal
    Cristian Tomasetti · 2019 · Science
  56. How is cancer complex?
    Anya Plutynski · 2021 · European Journal for Philosophy of Science
  57. Aging and Age-Related Epigenetic Drift in the Pathogenesis of Leukemia and Lymphomas: New Therapeutic Targets
    Alessandro Allegra, Santino Caserta, Giuseppe Mirabile, Sebastiano Gangemi · 2023 · Cells
  58. Detailed molecular characterisation of acute myeloid leukaemia with a normal karyotype using targeted DNA capture
    Nathalie Conte, Ignacio Varela, Carolyn S. Grove, Nicla Manes, Kosuke Yusa, Thaidy Moreno-Rodriguez, Anne Segonds-Pichon, Anthony J. Bench, Emma J. Gudgin, Bram Herman et al. · 2013 · Leukemia
  59. Genomic Characterization of Acute Leukemias
    Sabina Chiaretti, Valentina Gianfelici, Giulia Ceglie, Robin Foà · 2014 · Medical Principles and Practice
  60. Secondary Acute Myeloid Leukemia
    Eric S. Winer · 2020 · Hematology/Oncology Clinics of North America
  61. Precision medicine in myeloid malignancies
    Jörg Westermann, Lars Bullinger · 2021 · Seminars in Cancer Biology
  62. DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation
    Majd D. Jawad, Michelle Afkhami, Yi Ding, Xiaohui Zhang, Peng Li, Kim Young, Mina Luqing Xu, Wei Cui, Yiqing Zhao, Stephanie Halene et al. · 2022 · Frontiers in Oncology
  63. Genome-wide assessment of recurrent genomic imbalances in canine leukemia identifies evolutionarily conserved regions for subtype differentiation
    Sarah C. Roode, Daniel Miller Rotroff, Anne C. Avery, Steven E. Suter, Dorothee Bienzle, Joshua David Schiffman, Alison A. Motsinger‐Reif, Matthew Breen · 2015 · Chromosome Research
  64. Genetic instability of modified stem cells - a first step towards malignant transformation?
    Doris Steinemann, Gudrun Göhring, Brigitte Schlegelberger · 2013 · Europe PMC (PubMed Central)
  65. Cytogenetic heterogeneity negatively impacts outcomes in patients with acute myeloid leukemia
    Bruno C. Medeiros, Megan K. D. Othus, M. Fang, Frederick R. Appelbaum, Harry Paul Erba · 2014 · Haematologica
  66. Implications of Tumor Clonal Heterogeneity in the Era of Next-Generation Sequencing
    Meagan A. Jacoby, Eric James Duncavage, Matthew J. Walter · 2015 · Trends in cancer
  67. TET2 mutations in cytogenetically normal acute myeloid leukemia: Clinical implications and evolutionary patterns
    Frédérik Damm, Birgit Markus, Felicitas R. Thol, Michael Alexander Morgan, Gudrun Göhring, Brigitte Schlegelberger, Jürgen Krauter, Michael Heuser, Olivier Bernard, Arnold Ganser · 2014 · Genes Chromosomes and Cancer
  68. Determinants and role of chromatin organization in acute leukemia
    Celestia Fang, Sridhar Rao, John D. Crispino, Panagiotis Ntziachristos · 2020 · Leukemia
  69. Clonal Hematopoiesis and Mutations of Myeloproliferative Neoplasms
    Lasse Kjær · 2020 · Cancers
  70. Profiling of somatic mutations and fusion genes in acute myeloid leukemia patients with FLT3-ITD or FLT3-TKD mutation at diagnosis reveals distinct evolutionary patterns
    Wei Ping Guan, Lei Zhou, Yan Li, Erna Yang, Yangyang Liu, Na Lv, Lin Na Fu, Yi� Ding, Nan Wang, Nan Fang et al. · 2021 · Experimental Hematology and Oncology
  71. Potential role of autophagy induced by FLT3-ITD and acid ceramidase in acute myeloid leukemia chemo-resistance: new insights
    Hamidreza Zalpoor, Maryam Bakhtiyari, Abdullatif Akbari, Fatemeh Aziziyan, Hooriyeh Shapourian, Mahsa Liaghat, Zahra Zare-Badie, Sheida Yahyazadeh, Vahideh Tarhriz, Mazdak Ganjalıkhani-Hakemi · 2022 · Cell Communication and Signaling
  72. Hematopoietic stem cell aging and chronic lymphocytic leukemia pathogenesis
    Yoshikane Kikushige, Toshihiro Miyamoto · 2014 · International Journal of Hematology
  73. Dysregulation of haematopoietic stem cell regulatory programs in acute myeloid leukaemia
    Silvia Basilico, Berthold Göttgens · 2017 · Journal of Molecular Medicine
  74. The multiple ways Wnt signaling contributes to acute leukemia pathogenesis
    Sheila Coelho Soares‐Lima, Maria S. Pombo‐de‐Oliveira, Flávia Raquel Gonçalves Carneiro · 2020 · Journal of Leukocyte Biology
  75. Biological implications of clonal hematopoiesis
    Tiago Cunha Luis, Adam C. Wilkinson, Isabel Beerman, Siddhartha Jaiswal, Liran I. Shlush · 2019 · Experimental Hematology
  76. Identification of key proteins in the signaling crossroads between wound healing and cancer hallmark phenotypes
    Andrés López‐Cortés, Estefanía Abarca, Leonardo Costa da Silva, Erick Velasteguí, Ariana León-Sosa, Germania Karolys, Francisco Cabrera, Andrés Caicedo · 2021 · Scientific Reports
  77. Clonal Architecture and Evolutionary Dynamics in Acute Myeloid Leukemias
    Matthieu Duchmann, Lucie Laplane, Raphaël Itzykson · 2021 · Cancers
  78. Association of clonal hematopoiesis mutations with clinical outcomes: A systematic review and meta‐analysis
    Malgorzata Klaudia Nowakowska, Taebeom Kim, Mikayla T. Thompson, Kelly L. Bolton, Anita Deswal, Steven H. Lin, Paul Scheet, Mackenzie R. Wehner, Kevin Thomas Nead · 2022 · American Journal of Hematology
  79. Identification of the Adapter Molecule MTSS1 as a Potential Oncogene-Specific Tumor Suppressor in Acute Myeloid Leukemia
    Mirle Schemionek, Behzad Kharabi Masouleh, Yvonne Klaile, Utz O. Krug, Katja Hebestreit, Claudia Schubert, Martin Dugas, Thomas Büchner, Bernhard Josef Wormann, Wolfgang Hiddemann et al. · 2015 · PLoS ONE
  80. Rhabdoid Tumors: An Initial Clue to the Role of Chromatin Remodeling in Cancer
    Ryan S. Lee, Charles W.M. Roberts · 2013 · Brain Pathology
  81. Relapse after Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes: Analysis of Late Relapse Using Comparative Karyotype and Chromosome Genome Array Testing
    Cecilia C.S. Yeung, Aaron Thomas Gerds, Min Fang, Bart Lee Scott, Mary E.D. Flowers, Ted Alan Gooley, H. Joachim Deeg · 2015 · Transplantation and Cellular Therapy
  82. Single cell analysis exposes intratumor heterogeneity and suggests that FLT3-ITD is a late event in leukemogenesis
    Roni Shouval, Liran I. Shlush, Shlomit Yehudai‐Resheff, Shahnaz Ali, Neta Pery, Ehud Y. Shapiro, Maty Tzukerman, Jacob M. Rowe, Tsila Zuckerman · 2014 · Experimental Hematology
  83. Minimal residual disease monitoring: the new standard for treatment evaluation of haematological malignancies?
    Mathieu Hauwel, Thomas Matthes · 2014 · Swiss Medical Weekly
  84. Constraints in cancer evolution
    Subramanian Venkatesan, Nicolai J. Birkbak, Charles Swanton · 2017 · Biochemical Society Transactions
  85. Cohesin mutations in myeloid malignancies made simple
    Aaron D. Viny, Ross L. Levine · 2017 · Current Opinion in Hematology
  86. Clonal Hematopoiesis in Aging
    Soo Jean Park, Rafael L. Bejar · 2018 · Current Stem Cell Reports
  87. The impact of next generation sequencing technologies on haematological research – A review
    Jessica S. Black, Manuel Salto‐Tellez, Ken Mills, Mark Alexander Catherwood · 2015 · Pathogenesis
  88. A single nucleotide polymorphism genotyping platform for the authentication of patient derived xenografts
    Jad El‐Hoss, Duohui Jing, Kathryn Evans, Cara E. Toscan, Jinhan Xie, Hyunjoo Lee, Renea A. Taylor, Mitchell G. Lawrence, Gail Petuna Risbridger, Karen L. MacKenzie et al. · 2016 · Oncotarget
  89. Concomitant germ‐line RUNX 1 and acquired ASXL 1 mutations in a T‐cell acute lymphoblastic leukemia
    Thomas Prébet, Nadine Carbuccia, Hana Raslová, Rémi Favier, Jérôme Rey, Christine Arnoulet, Norbert Vey, William Vainchenker, Daniel Birnbaum, Julien Mozziconacci · 2013 · European Journal Of Haematology
  90. Accurate detection of subclonal single nucleotide variants in whole genome amplified and pooled cancer samples using HaloPlex target enrichment
    Eva Berglund, Carl Mårten Lindqvist, Shahina Hayat, Elin Övernäs, Niklas Henriksson, Jessica Nordlund, Per Wahlberg, Erik Forestier, Gudmar Lönnerholm, Ann‐Christine Syvänen · 2013 · BMC Genomics
  91. Telomerase: The Devil Inside
    Mukesh Kumar, André Lechel, Çagatay Güneş · 2016 · Genes
  92. Overcoming mutational complexity in acute myeloid leukemia by inhibition of critical pathways
    Yoriko Saito, Yoshiki Mochizuki, Ikuko Ogahara, Takashi Watanabe, Leah J. Hogdal, Shinsuke Takagi, Kaori Sato, Akiko Kaneko, Hiroshi Kajita, Naoyuki Uchida et al. · 2017 · Science Translational Medicine
  93. Tracking hematopoietic stem cells and their progeny using whole-genome sequencing
    Henry Lee-Six, David G. Kent · 2020 · Experimental Hematology
  94. Measurable residual disease in elderly acute myeloid leukemia: results from the PETHEMA-FLUGAZA phase 3 clinical trial
    Catia Patricia Simoes, Bruno Paiva, David Martínez‐Cuadrón, Juan Bergua, Susana Vives, Lorenzo Algarra, Mar Tormo, Pilar Martı́nez, Josefina Serrano, Pilar Herrera et al. · 2021 · Blood Advances
  95. Liquid biopsies in pediatric oncology: opportunities and obstacles
    R. Taylor Sundby, Alexander C. Pan, Jack F. Shern · 2021 · Current Opinion in Pediatrics
  96. Clonal Evolution in Healthy and Premalignant Tissues: Implications for Early Cancer Interception Strategies
    Jayant K. Rane, Alexander M. Frankell, Clare E. Weeden, Charles Swanton · 2023 · Cancer Prevention Research
  97. MRD in AML: It is time to change the definition of remission
    Gert Jan Ossenkoppele, Gerrit Jan Schuurhuis · 2014 · Best Practice & Research Clinical Haematology
  98. Activity of Bruton's tyrosine-kinase inhibitor ibrutinib in patients with CD117-positive acute myeloid leukaemia: a mechanistic study using patient-derived blast cells
    Stuart A. Rushworth, Genevra Pillinger, Amina M Abdul-Aziz, Rachel E. Piddock, Manar S. Shafat, Megan Y. Murray, Lyubov Zaitseva, Matthew J. Lawes, David J. MacEwan, Kristian M. Bowles · 2015 · The Lancet Haematology
  99. BreakTrans: uncovering the genomic architecture of gene fusions
    Ken Chen, Nicholas E. Navin, Yong Wang, Heather K. Schmidt, John W. Wallis, Beifang Niu, Xian Fan, Hao Zhao, Michael D. McLellan, Katherine A. Hoadley et al. · 2013 · Genome biology
  100. Structural Maintenance of Chromosomes protein 1: Role in Genome Stability and Tumorigenesis
    Fei Yi, Zhuo Wang, Jingwei Liu, Ying Zhang, Zhijun Wang, Hongde Xu, Xiaoman Li, Ning Bai, Liu Cao, Xiaoyu Song · 2017 · International Journal of Biological Sciences